October 2018 - December 2023 time-series analysis of pediatric RSV immunizations and RSV-associated hospitalizations
Cartwright, B. M. G.; Gratzl, S.; Rodriguez, P. J.; Baker, C.; Stucky, N.
Show abstract
This study describes two population under age two 1) who received an RSV immunization and 2) experienced RSV-associated hospitalizations since 2018. Results show low uptake of the RSV immunization. RSV-associated hospitalizations exhibited earlier and higher peaks in the 2021/22 and 2022/23 seasons compared to previous years.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Inpatient Burden of Respiratory Syncytial Virus Infection and Influenza in Children Younger than 5 years in Japan, 2011-2022: A database study 95%
- Unveiling the spectrum of Respiratory Syncytial Virus disease in Adults: from Community to Hospital 94%
- Relative timing of RSV epidemics in summer 2021 across the US was similar to a typical RSV season 93%
Similar papers in this journal
- Clinical and economic inpatient burden of respiratory syncytial virus (RSV) infections in children < 2 years of age in Germany, 2014-2019: a retrospective health claims analysis 93%
- Symptoms at presentation for patients admitted to hospital with Covid-19: results from the ISARIC prospective multinational observational study 89%
- Higher Vaccination Rate Predicts Reduction in SARS-CoV-2 Transmission across the United States 89%
Similar papers in this journal
- Evaluating the Effectiveness of Nirsevimab in Reducing Pediatric RSV Hospitalizations in Spain 94%
- Breakthrough SARS-CoV-2 Infections after Vaccination in North Carolina 90%
- A First in Human Trial to Evaluate the Safety and Immunogenicity of a G Protein Based Recombinant Respiratory Syncytial Virus Vaccine in Healthy Adults 18-45 Years 90%
Similar papers in this journal
- Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infants 93%
- A multivalent RSV vaccine based on the Modified Vaccinia Ankara vector shows moderate protection against disease caused by RSV in older adults in a Phase 3 clinical study 93%
- Evaluation of the costs of care for pediatric patients hospitalized for RSV: a retrospective cohort study in Belgium 93%
Similar papers in this journal
- SARS-CoV-2 viral clearance and viral load kinetics in young children (1-6 years) compared to adults: Results of a longitudinal study in Germany 90%
- Streptococcus pneumoniae serotypes carried by young children and their association with Acute Otitis Media during the period 2016 - 2019. 89%
- SARS-CoV-2 surveillance (09/2020 - 03/2021) in elementary schools and daycare facilities in Bavaria 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.